94191-12-5

Basic information

• Product Name: 3-bromothiopheno[3,2-b]pyridine
• Synonyms: 3-bromothiopheno[3,2-b]pyridine;3-Bromothieno[3,2-b]pyridine;Thieno[3,2-b]pyridine,3-bromo-
• CAS NO: 94191-12-5
• Molecular Formula: C₇H₄BrNS
• Molecular Weight: 214.086
• Product Categories: Building Blocks;Thieno[x,x-y]pyridine
• Mol File: 94191-12-5.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 308.327 °C at 760 mmHg
• Flash Point: 140.271 °C
• Appearance: /
• Density: 1.748±0.06 g/cm3 (20 ºC 760 Torr)
• Vapor Pressure: 0.001mmHg at 25°C
• Refractive Index: 1.718
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 3-bromothiopheno[3,2-b]pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 3-bromothiopheno[3,2-b]pyridine(94191-12-5)
• EPA Substance Registry System: 3-bromothiopheno[3,2-b]pyridine(94191-12-5)

Safety Data

• Hazardous Substances Data: 94191-12-5(Hazardous Substances Data)

Usage

General Description

3-Bromothiopheno[3,2-b]pyridine is a chemical compound with the molecular formula C9H6BrNS. It is a heterocyclic aromatic compound with a fused pyridine and thiophene ring. 3-bromothiopheno[3,2-b]pyridine is often used as a building block in organic synthesis, particularly in the development of pharmaceuticals and agrochemicals. It has been studied for its potential biological activities, including its antimicrobial and anti-fungal properties. Additionally, 3-Bromothiopheno[3,2-b]pyridine has been explored for its use in materials science, such as in the development of organic semiconductors and liquid crystals. Overall, this chemical compound has versatile applications in various fields and continues to be of interest for further research and development.

InChI:InChI=1/C7H4BrNS/c8-5-4-10-6-2-1-3-9-7(5)6/h1-4H

Upstream product

• 69627-03-8 7-chlorothieno[3,2-b]pyridine 
• 603305-89-1 7-bromothieno[3,2-b]pyridine 
• 69627-02-7 thieno[3,2-b]pyridin-7-ol 
• 40925-53-9 benzyl 2-(2-pyridyl)vinyl sulfide 
• 272-67-3 thieno[3,2-b]pyridine 

Relevant articles and documents

2-AMINO-N-(AMINO-OXO-ARYL-LAMBDA6-SULFANYLIDENE)ACETAMIDE COMPOUNDS AND THEIR THERAPEUTIC USE

The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain 2-amino-N-(amino-oxo-aryl-λ6- sulfanylidene)acetamide compounds (referred to herein as ANASIA compounds) that, inter alia, inhibit (e.g., selectively inhibit) bacterial aminoacyl-tRNA synthetase (aaRS) (e.g., bacterial leucyl-tRNA synthetase, LeuRS). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit (e.g., selectively inhibit) bacterial aminoacyl-tRNA synthetase; to treat disorders that are ameliorated by the inhibition (e.g., selective inhibition) of bacterial aminoacyl-tRNA synthetase; to treat bacterial infections; etc.

IMIDAZOPYRIDAZINE COMPOUNDS

The present invention relates to novel substituted imidazo[1,2-b] pyridazine compounds of Formula (I) pharmaceutical compositions thereof, and the use such compounds as corticotropin releasing factor 1 (CRF1) receptor antagonists in the treatment of psychiatric disorders and neurological diseases.